Acute promyelocytic leukemia
Acute promyelocytic leukemia (APL) is a special type of acute myeloid leukemia (AML), which is classified as acute myeloid leukemia M3 by the FAB collaboration group. In recent years, with the continuous improvement of the understanding of the biological characteristics of APL cells and the improvement of treatment methods, the treatment results and prognosis have been greatly improved, and the early mortality rate has been significantly reduced.
-
Site of disease:
Bone marrow blood vessels -
Infectious :
Not contagious -
Frequent population:
Most common in young and middle-aged people -
Related symptoms:
Weakness in the limbs Enlarged spleen Enlarged liver Swelling of axillary lymph nodes Swelling of lymph nodes -
Concurrent disease:
Related Drugs
Compound Huangdai Tablets
Manufacturer:
Tianchang Yifan Pharmaceutical Co., Ltd.
TRETINOIN- tretinoin_capsule
Indication: Tretinoin capsules are indicated for the induction of remission in adults and pediatric patients 1 year of age and older with acute promyelocytic leukemia (APL) characterized by the presence of the t(15;17) translocation or PML/RARalpha gene expression, and who are refractory to or who have relapsed from anthracycline chemotherapy or for whom anthracycline-based chemotherapy is contraindicated. Tretinoin capsules are a retinoid indicated for induction of remission in adults and pediatric patients 1 year of age and older with acute promyelocytic leukemia (APL), characterized by presence of t(15;17) translocation or presence of PML/RARalpha gene expression, and who are refractory to or who have relapsed from anthracycline chemotherapy or for whom anthracycline-based chemotherapy is contraindicated.
Manufacturer:
Major Pharmaceuticals
TRETINOIN- tretinoin_capsule, liquid filled
Indication: Tretinoin capsules are indicated for the induction of remission in adults and pediatric patients 1 year of age and older with acute promyelocytic leukemia (APL) characterized by the presence of the t(15;17) translocation or PML/RARalpha gene expression, and who are refractory to or who have relapsed from anthracycline chemotherapy or for whom anthracycline-based chemotherapy is contraindicated. Tretinoin capsules are a retinoid indicated for induction of remission in adults and pediatric patients 1 year of age and older with acute promyelocytic leukemia (APL), characterized by presence of t(15;17) translocation or presence of PML/RARalpha gene expression, and who are refractory to or who have relapsed from anthracycline chemotherapy or for whom anthracycline-based chemotherapy is contraindicated.
Manufacturer:
Teva Pharmaceuticals USA, Inc.
ARSENIC TRIOXIDE- arsenic trioxide_injection, solution
Indication: Arsenic trioxide injection is an arsenical indicated: For induction of remission and consolidation in patients with APL who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy, and whose APL is characterized by the presence of the t(15;17) translocation or PML/RAR-alpha gene expression. 2 Arsenic trioxide injection is indicated for induction of remission and consolidation in patients with APL who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy, and whose APL is characterized by the presence of the t(15;17) translocation or PML/RAR-alpha gene expression.
Manufacturer:
STI Pharma LLC